Company Data
Unity Biotechnology Inc.
Ticker
UBX
Current Price
$1.94 -5.37%
Market Cap
$32.7M
Price Target
Refer to Report
Volume
98.8K
52wk Range
$0.9397 - $3.1
Overview
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.